Our innovative treatments, including Semaglutide, are designed to address the root causes of weight gain by regulating appetite, improving blood sugar control, and boosting metabolic health
More bleeding at the site
Blood in stool : Either bright red blood or black, tarry stools, which may indicate gastrointestinal bleeding
doi: 10.1016/j.molmet.2023.101850 38 LeiCTWeiYHTangHWenQYeCZhangCet al
(2011) Analysis of the glucagon receptor first extracellular loop by the substituted cysteine accessibility method
The bottom line: Our findings suggest that GLP-1RA and SGLT2i (and especially SGLT2i with the lowest number needed to treat (NNT) for nearly all study outcomes) may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate risk for CVD, building on and consistent with existing RCT evidence in the high-risk population. This report highlights potential preference for GLP-1 drugs as a first-line treatment for Type 2 diabetes related to its cardioprotective effect